TP53 and gonorrhea: The Kaplan-Meier survival analysis showed patients (n = 16) with the mutation at p.A138V in TP53 has significantly poorer survival than patient (PAC and/or PDAC) having wild type variant (p = 0.02) (Fig. 4a).